Evidence map›Paper›PMID 34944434›Full record

ReviewBiomolecules2021

Insight into the Double-Edged Role of Ferroptosis in Disease.

Lei Zhang, Ruohan Jia, Huizhen Li, Huarun Yu, Keke Ren, Shuangshuang Jia, Yanzhang Li, Qun Wang

Abstract readReview
In one paragraph

Review in Biomolecules, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lei ZhangHenan International Joint Laboratory for Nuclear Protein Regulation, Henan University, Kaifeng 475004, China.ORCID 0000-0002-7781-3478
Ruohan JiaHenan International Joint Laboratory for Nuclear Protein Regulation, Henan University, Kaifeng 475004, China.
Huizhen LiHenan International Joint Laboratory for Nuclear Protein Regulation, Henan University, Kaifeng 475004, China.
Huarun YuSchool of Clinical Medicine, Henan University, Kaifeng 475004, China.
Keke RenSchool of Clinical Medicine, Henan University, Kaifeng 475004, China.
Shuangshuang JiaSchool of Basic Medical Sciences, Henan University, Kaifeng 475004, China.
Yanzhang LiSchool of Basic Medical Sciences, Henan University, Kaifeng 475004, China.
Qun WangSchool of Basic Medical Sciences, Henan University, Kaifeng 475004, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ferroptosis, a newly described type of iron-dependent programmed cell death that is distinct from apoptosis, necroptosis, and other types of cell death, is involved in lipid peroxidation (LP), reactive oxygen species (ROS) production, and mitochondrial dysfunction. Accumulating evidence has highlighted vital roles for ferroptosis in multiple diseases, including acute kidney injury, cancer, hepatic fibrosis, Parkinson's disease, and Alzheimer's disease. Therefore, ferroptosis has become one of the research hotspots for disease treatment and attracted extensive attention in recent years. This review mainly summarizes the relationship between ferroptosis and various diseases classified by the system, including the urinary system, digestive system, respiratory system, nervous system. In addition, the role and molecular mechanism of multiple inhibitors and inducers for ferroptosis are further elucidated. A deeper understanding of the relationship between ferroptosis and multiple diseases may provide new strategies for researching diseases and drug development based on ferroptosis.

Indexed as

FerroptosisDigestive System DiseasesGene Expression RegulationGene Regulatory NetworksHumansLipid PeroxidationMolecular Targeted TherapyNervous System DiseasesReactive Oxygen SpeciesUrologic DiseasesReactive Oxygen SpeciesferroptosisinducersinhibitorsROSsystemic diseases

Identifiers

PMID34944434
PMCPMC8699194

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.